<- Go Home
HAEMATO AG
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO brand, and cosmetics under the brand M1 SELECT, as well as supplies third party-products. It serves clinics, pharmacies, wholesalers, and medical test centers. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany. HAEMATO AG operates as a subsidiary of M1 Kliniken AG.
Market Cap
EUR 68.5M
Volume
N/A
Cash and Equivalents
EUR 13.9M
EBITDA
EUR 9.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 19.7M
Profit Margin
7.56%
52 Week High
EUR 13.60
52 Week Low
EUR 8.20
Dividend
0.47%
Price / Book Value
0.46
Price / Earnings
6.99
Price / Tangible Book Value
1.18
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
EUR 9.2M
Return on Equity
6.51%
Return on Assets
3.22
Cash and Short Term Investments
EUR 13.9M
Debt
EUR 3.1M
Equity
EUR 149.4M
Revenue
EUR 260.8M
Unlevered FCF
EUR 5.0M
Sector
Health Care Providers and Services
Category
N/A